Amgen
Search results
Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
Gilead Sciences, Inc. (/ ˈ ɡ ɪ l i ə d /) is an American biopharmaceutical company headquartered in Foster City, California that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
Advancing Global Health. We invest in programs that aim to eliminate some of the world’s most challenging public health threats, enable access to medicines and help fight the stigma that prevents people from seeking care.
Jun 20, 2024 · “With zero infections and 100% efficacy, twice-yearly lenacapavir has demonstrated its potential as an important new tool to help prevent HIV infections,” said Merdad Parsey, MD, PhD, Chief Medical Officer, Gilead Sciences.
Working at Gilead. Gilead has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a better, healthier world for all people. We have commercialized more than 25 innovative medicines, helping to transform treatment for people living with HIV, viral hepatitis, cancer and other life-threatening ...
Gilead Sciences is a biopharmaceutical company that researches, develops, and sells therapies for treating HIV, hepatitis B, hepatitis C, and certain cancers.
With 21 marketed products, we work in the therapeutic areas of HIV, liver disease, oncology, inflammatory diseases and respiratory diseases supporting full-scale commercial, medical, regulatory, finance and legal operations for both Gilead Sciences and Kite, a Gilead Company, in Canada.
